Profil
Shamel Costandy worked as the Chief Financial Officer at Divergent Energy Services Corp.
from 2008 to 2010.
He also worked as a Financial Controller at Trillium Therapeutics ULC.
Anciens postes connus de Shamel Costandy
| Sociétés | Poste | Fin |
|---|---|---|
| DIVERGENT ENERGY SERVICES CORP. | Directeur Financier/CFO | 08/12/2010 |
| TRILLIUM THERAPEUTICS | Comptroller/Controller/Auditor | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIVERGENT ENERGY SERVICES CORP. | Industrial Services |
| Entreprise privées | 1 |
|---|---|
Trillium Therapeutics ULC
 Trillium Therapeutics ULC BiotechnologyHealth Technology Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada. | Health Technology |
